IP Verse

Methods And Compositions For Treating Myelofibrosis

Patent No. EP3490582 (titled "Methods And Compositions For Treating Myelofibrosis") was filed by Acceleron Pharma on Jul 26, 2017. The application was issued on Jun 12, 2024.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALD PATENTANWALTSMar 12, 2025MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
WUESTHOFF & WUESTHOFFMar 10, 2025WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3490582

ACCELERON PHARMA
Application Number
EP17835212A
Filing Date
Jul 26, 2017
Status
Granted And Under Opposition
May 10, 2024
Publication Date
Jun 12, 2024
External Links
Slate, Register , Google Patents